Home › Therapeutic areas › Infectious Disease › HIV

HIV (2 companies)

Companies with an active program in HIV.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
IMCR Immunocore DermatologyInfectious Disease+2 1 Approved $1.44B 12
VIR Vir Biotechnology Infectious DiseaseOncology Rare 1 Phase 3 $1.58B 6